FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Gilead Sciences | Parion Sciences | GS9411

Parion gets $5M milestone from Gilead

Tools

North Carolina' s Parion Sciences and Gilead have initiated a Phase I clinical trial of GS9411, and experimental therapy designed to increase airway hydration for the treatment of pulmonary disease. Parion will get a $5 million milestone payment from Gilead. Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Gilead Sciences   Parion Sciences   GS9411  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.